La Fleur & Godfrey LLC Gilead Sciences, Inc. Transaction History

La Fleur & Godfrey LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Oct 29, 2019	SELL	$62.51 - $69.0 $4.86 Million - $5.36 Million	-77,704 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$61.87 - $69.38 $88,041 - $98,727	-1,423 Reduced 1.8%	77,704 $5.25 Million
Q1 2019 Apr 17, 2019	SELL	$62.53 - $70.05 $2.02 Million - $2.27 Million	-32,344 Reduced 29.02%	79,127 $5.14 Million
Q4 2018 Feb 12, 2019	SELL	$60.54 - $79.0 $1.27 Million - $1.66 Million	-21,023 Reduced 15.87%	111,471 $6.97 Million
Q3 2018 Dec 13, 2018	BUY	$71.28 - $78.92 $1.9 Million - $2.1 Million	26,626 Added 25.15%	132,494 $10.2 Million
Q2 2018 Dec 13, 2018	BUY	$64.88 - $75.68 $389,669 - $454,534	6,006 Added 6.01%	105,868 $7.5 Million
Q1 2018 Dec 13, 2018	BUY	$72.84 - $88.8 $2.64 Million - $3.22 Million	36,230 Added 56.94%	99,862 $7.53 Million
Q4 2017 Jan 22, 2018	BUY	$71.15 - $83.52 $4.53 Million - $5.31 Million	63,632	63,632 $4.56 Million

1,926

993M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of La Fleur & Godfrey LLC, based on Form 13F filings with the SEC.

Stay updated on La Fleur & Godfrey LLC with notifications on news.